Skip to main content

Table 1 Clinical characteristics of our study population and controls

From: “Non alcoholic fatty liver disease and eNOS dysfunction in humans”

Variable Controls
n: 15
Overall NAFLD
n: 54
p NAFL
n: 21
NASH
n: 33
p
Age 45,55 ± 10,24 49,89 ± 1,05 0.176 48,58 ± 10,874 50.27 ± 10.254 0.566
Sex M/F 10/5
[66,7%/32,3%]
38/16
[70,4%/27,8%]
0.784 14/7
[66,7%/33,3%]
24/9
[72,7%/27,3%]
0.634
BMI 22,91 ± 2,76 30,17 ± 3,86 <0.001 29,51 ± 3,31 30,6 ± 4,21 0.320
Hypertension 0 21 [38,9%] 0.005 7 [33,3%] 14 [42,4%] 0.521
Diabetes 0 11 [22,2%] 0.057 4 [19,0%] 7 [21,2%] 0.847
Dyslipidemia 0 35 [64,8%] <0.001 16 [76,2%] 19 [57,6%] 0.163
Obesity 3 [20,00%] 29 [53,7%] 0.021 12 [57,1%] 17 [51,5%] 0.686
Insulin 17,65 ± 5,95 14,08 ± 2,06 21,18 ± 6,98 <0.001
HOMA 4,36 ± 1,72 3,10 ± 0,08 5,24 ± 1,58 <0.001
Metabolic Syndrome 0 19 [35,2%] 0.007 7 [33,3%] 12 [36,4%] 0.820
Cirrhosis 0 6 [11,1%] 0.177 0 6 [18,2%] 0.077
ALT 26,44 ± 9,56 67,56 ± 44,37 <0.001 66,00 ± 43,65 68,33 ± 46,64 0.085